price
HU
NASDAQ · HUMA
Humacyte, Inc.
Healthcare · Biotechnology
$0.58
Up+$0.01 (+1.83%)
Updated Sep 18, 2026, 11:10 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 187.81M
- P/E ratio
- -10.7
- Dividend yield
- 0.00%
- 52-week range
- $0.53 – $2.55
- Volume
- 2.9M
- Avg. volume
- 5.36M
Price performance
HUMA price history
1M range · 20 trading sessions · Daily adjusted prices
HUMA closed at $0.58 after 20 trading sessions, down 15.60% for the selected period.
- Last close
- $0.58
- Period change
- -15.60%
- Period low
- $0.55
- Period high
- $0.70
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $0.5946 | $0.598 | $0.5652 | $0.5751 | 2.9M |
| Sep 16, 2026 | $0.5582 | $0.596 | $0.55 | $0.57 | 4.96M |
| Sep 15, 2026 | $0.56 | $0.5696 | $0.54 | $0.5516 | 3.21M |
| Sep 14, 2026 | $0.55 | $0.5749 | $0.55 | $0.561 | 3.16M |
| Sep 11, 2026 | $0.5759 | $0.5878 | $0.559 | $0.5676 | 2.26M |
| Sep 10, 2026 | $0.58 | $0.58 | $0.56 | $0.5671 | 2.67M |
| Sep 9, 2026 | $0.5905 | $0.60 | $0.5751 | $0.579 | 2.92M |
| Sep 8, 2026 | $0.6095 | $0.6099 | $0.58 | $0.5949 | 2.4M |
| Sep 4, 2026 | $0.591 | $0.6101 | $0.5828 | $0.6049 | 2.97M |
| Sep 3, 2026 | $0.6076 | $0.6099 | $0.584 | $0.596 | 3.02M |
| Sep 2, 2026 | $0.5711 | $0.6111 | $0.57 | $0.5966 | 5.18M |
| Sep 1, 2026 | $0.598 | $0.6014 | $0.57 | $0.5704 | 16.54M |
| Aug 31, 2026 | $0.65 | $0.65 | $0.5839 | $0.6014 | 13.54M |
| Aug 28, 2026 | $0.69 | $0.6954 | $0.6401 | $0.6501 | 4.92M |
| Aug 27, 2026 | $0.70 | $0.7082 | $0.687 | $0.6927 | 2.96M |
| Aug 26, 2026 | $0.71 | $0.7119 | $0.67 | $0.6816 | 5.68M |
| Aug 25, 2026 | $0.663 | $0.73 | $0.6601 | $0.7012 | 5.92M |
| Aug 24, 2026 | $0.675 | $0.6936 | $0.6424 | $0.6622 | 3.76M |
| Aug 21, 2026 | $0.6741 | $0.70 | $0.6345 | $0.6422 | 9.37M |
| Aug 20, 2026 | $0.7074 | $0.715 | $0.6627 | $0.6814 | 6.65M |
Latest HUMA news
The latest Smart Investors Daily articles mentioning HUMA.
Stock researchCompany · Financials
Loading stock research…